Navigation Links


XXI in Medical News

Photos: Compact Barbell System With Flat, Streamlined Profile Travels Easily and Stores Conveniently

...are shipped with a custom, zippered tote bag. For more information on The Burn Machine, log on at http://www.theburnmachine.com, or call Portfolio xxi at 586-447-2001. ...
XXI in Medical Technology

Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)

SOUTH SAN FRANCISCO, July 02, 2007 /PRNewswire/ -- Portola Pharmaceuticals, Inc. announced today that it will present clinical and preclinical data on its oral Factor Xa inhibitor and on its intravenous and oral ADP receptor antagonist at the XXI Congress of the International Society of Thrombosis...

Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis

SAN FRANCISCO, July 10, 2007 /PRNewswire/ -- Portola Pharmaceuticals, Inc. announced positive Phase II data on its lead compound, PRT054021, an oral Factor Xa inhibitor, today at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH) in Geneva, Switzerland. The EXPERT t...

Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis

HORSHAM, Pa.--(BUSINESS WIRE)--Jul 11, 2007 - Neose Technologies, Inc. (Nasdaq GM:NTEC) today announced that two poster presentations were presented with its collaborative partner, Novo Nordisk A/S, relating to GlycoPEGylated recombinant Factor VIIa at the XXIst Congress of the International Societ...

Video: The Arizona Heart Institute Announces the Largest Worldwide Experience with Endoluminal Grafting to Treat Thoracic Aortic Aneurysms and Related Pathologies

...pathologies: A single center experience International Society of Endovascular Specialists International Congress xxi Endovascular Interventions ...

Portola Pharmaceuticals Announces Positive Phase II Results for PRT054021 for Prevention of Venous Thromboembolism Following Total Knee Replacement Surgery

... Data to be Presented at the xxi Congress of the International Society on Thrombosis and Haemostasis SOUTH ...und into further clinical trials. Data from EXPERT will be presented at the xxi Congress of the International Society on Thrombosis and Haemostasis in Gene...

Othera Pharmaceuticals Announces Upcoming Presentation Based Upon Expanded Understanding of Lead Compound Mechanism of Action

...ell as studies on novel, orally-available analog compounds under development for non-ophthalmic indications. Dr. Mousa's talk will be presented at the xxi International Society on Thrombosis and Haemostasis (ISTH) Congress in Geneva, Switzerland on July 9, 2007. The ISTH holds its congress every other ye...

Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery

... GENEVA--(BUSINESS WIRE)--Jul 8, 2007 - Late-breaking Phase III clinical trial data presented today at the xxi International Society on Thrombosis and Haemostasis (ISTH) Congress demonstrate that once-daily rivaroxaban achieved superior efficacy in the preventi...

Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery

...Compared with Enoxaparin with Similarly Low Bleeding Rates GENEVA, July 8, 2007 - Late-breaking Phase III clinical trial data presented today at the xxi International Society on Thrombosis and Haemostasis (ISTH) Congress demonstrate that once-daily rivaroxaban (Xarelto®) achieved superior efficacy ...
XXI in Biological News

IRB Barcelona to coordinate two European projects on biomedicine

...r professor at the University of Barcelona, will coordinate a pioneering project to fight against diabetes, a disease described as the epidemic of the xxi century. The MITIN Project is innovative because it will be the first time that bioinformatics is applied to obtain information about complex diseases...

CO2 increase in the atmosphere augments tolerance of barley to salinity

...ction in its growth. The Intergovernmental Panel on Climate Change (IPCC) predicts that the CO 2 concentration in the atmosphere at the end of the xxi century will double current levels. An increase contributed to by human activity through the combustion of fossil fuels and the destruction of forests...
Other TagsEndotoxinExhaustExhaustBeaconBeaconCatchCatchVerticalOrbitOrbit
(Date:12/1/2009)...ec. 1 The government of Mexico Cit...er for biomedical and nanomedical research, called...earch and development will be integrated with the ...Spanish speaking university in the world. The res...2010, has been designed by the internationally-acc...
(Date:12/1/2009)...sh., Dec 1 Edifecs, Inc., the prov...ernization solutions announced an enhanced release...PAA 4010A1 to HIPAA 5010 migrations. XEngine Trans...on maps, allows generation of test data and permit...roduction, thus addressing most requirements for o...
(Date:12/1/2009)...al and South America, study finds , , TU... of intensive care unit patients worldwide suffer ...the hospital, a new study finds. , Researchers ...07) on 13,796 patients, aged 18 and older, in 1,26... of patients were classified as infected and 71 pe...
(Date:12/1/2009)...because pandemic,s course remains unpredictable ,...U.S. health official said Tuesday that H1N1 swine ..., but many experts agreed the virus could return i...espread in 32 states -- down from 43 states the we...U.S. Centers for Disease Control and Prevention (C...
(Date:12/1/2009)...ractitioners of any medical, legal or business req... sigh of relief this week with the release of ,Dic...eleased over the holiday weekend, allows anyone re...to do so quickly and seamlessly using just the iPh...December 1, 2009 -- The iPhone App, released by Fl...
Breaking Medicine News(10 mins):Health News:Mexico City to Build World-Class Hub for Medical Research 2Health News:Edifecs Delivers Enhanced HIPAA 4010A1 to 5010 Migration Capabilities for Healthcare Organizations 2Health News:Edifecs Delivers Enhanced HIPAA 4010A1 to 5010 Migration Capabilities for Healthcare Organizations 3Health News:Half of ICU Patients Suffer From Infections 2Health News:Swine Flu Waning, But Could Return 2Health News:Swine Flu Waning, But Could Return 3Health News:Medical and Legal Professionals Find Relief Leveraging Apple iPhone App for Dictation and Transcription 'On the Go' 2
(Date:12/1/2009)...al Primate Research Center, Emory University, have...ie voles, an important step toward unlocking the g...ation of this technology will enable scientists to... help identify the brain mechanisms of social bond...cement may also have important implications for un...
(Date:12/1/2009)...rsity cancer researchers have developed a tumor-a...nd blocks the growth of new tumor blood vessels. ,...ill cancer cells oncolytic viruses might be more... also carry a gene for a protein that inhibits blo...atin, is normally produced in the brain. In this s...
(Date:12/1/2009)...Newswire/ -- iQor, a global provider of business p... the 2009 InfoWorld 100 Awards Top 100 IT projec...Q21. This was the first submission for iQor. ,,...igious list of companies," said Vikas Kapoor, pres...orming the way we do business, allowing us to work...
Breaking Biology News(10 mins):Yerkes researchers create first transgenic prairie voles 2Tumor-attacking virus strikes with 'one-two punch' 2iQor Named to InfoWorld 100 List of Top IT Projects of 2009 2Chindex International Inc to Report First Quarter Fiscal 2010 Financial Results 53379 1Chindex International Inc to Report First Quarter Fiscal 2010 Financial Results 53379 2Advanced Life Sciences Receives Complete Response Letter From FDA for Restanza 28TM 29 28Cethromycin 29 in Community Acquired Pneumonia 13312 1Advanced Life Sciences Receives Complete Response Letter From FDA for Restanza 28TM 29 28Cethromycin 29 in Community Acquired Pneumonia 13312 2Advanced Life Sciences Receives Complete Response Letter From FDA for Restanza 28TM 29 28Cethromycin 29 in Community Acquired Pneumonia 13312 3Advanced Life Sciences Receives Complete Response Letter From FDA for Restanza 28TM 29 28Cethromycin 29 in Community Acquired Pneumonia 13312 4Advanced Life Sciences Receives Complete Response Letter From FDA for Restanza 28TM 29 28Cethromycin 29 in Community Acquired Pneumonia 13312 5Post Recession Incomes Will Be Hit Hard by Health Care Spending for Middle Class Working Families PENN Analysis Shows 53376 1Post Recession Incomes Will Be Hit Hard by Health Care Spending for Middle Class Working Families PENN Analysis Shows 53376 2Post Recession Incomes Will Be Hit Hard by Health Care Spending for Middle Class Working Families PENN Analysis Shows 53376 3Post Recession Incomes Will Be Hit Hard by Health Care Spending for Middle Class Working Families PENN Analysis Shows 53376 4
Other Contentsprincipleprincipleprincipleprincipleprincipleprincipleprincipleprincipleprinciplehardyhepatitishepatitishepatitishepatitishepatitishepatitishepatitishepatitishelperhelperhelperhelperhelperhelperherbivorehermaphrodite